Medifast, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $27.7M | $17.8M | $20.1M | $13.2M | $24.0M | $15.9M | $18.5M | $19.6M |
| Depreciation & Amortization | $4.2M | $5.4M | $7.1M | $8.1M | $7.9M | $8.4M | $8.3M | $5.9M |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | — | — | $428.0K | $572.0K | $456.0K | — |
| Stock-Based Compensation | $4.3M | $3.4M | $3.1M | $3.9M | $3.2M | $2.9M | $2.5M | $2.6M |
| Net Cash from Operating Activities | $43.2M | $25.4M | $29.4M | $25.5M | $42.4M | $40.3M | $34.9M | $28.8M |
| Investing Activities | ||||||||
| Capital Expenditures | $3.2M | $2.9M | $2.8M | $7.0M | $11.4M | $8.1M | $14.3M | $12.1M |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $-3.2M | $-2.0M | $-189.0K | $-2.5M | $-22.6M | $-11.7M | $-16.9M | $-23.5M |
| Financing Activities | ||||||||
| Dividends Paid | $15.4M | $11.9M | — | — | — | — | — | — |
| Stock Repurchases | — | — | $10.5M | $33.9M | $20.1M | $2.8M | $20.4M | $35.0K |
| Net Cash from Financing Activities | $-17.4M | $-12.9M | $-11.7M | $-34.9M | $-23.3M | $-2.9M | $-20.9M | $1.3M |
| Net Change in Cash | $22.6M | $10.4M | $17.6M | $-11.9M | $-3.6M | $25.7M | $-2.9M | $6.6M |
| Free Cash Flow | $40.0M | $22.5M | $26.6M | $18.5M | $31.0M | $32.1M | $20.6M | $16.7M |